Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABC.L Share News (ABC)

  • There is currently no data for ABC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Tuesday broker round-up UPDATE

Tue, 22nd Jul 2014 09:37

Abcam: N+1 Singer places both its target price (prev.: 346p) and its sell recommendation under review.Amiad Water Systems: Oriel lowers target price from 350p to 340p and retains a buy recommendation.Ashmore Group: Espirito Santo ups target price from 371p to 404p, while downgrading to neutral.Avingtrans: FinnCap upgrades from hold to buy with a target price of 170p.Bodycote: Jefferies reduces target price from 895p to 825p and reiterates a buy recommendation.Brammer: Jefferies cuts target price from 495p to 445p and stays with its hold recommendation.Elementis: Canaccord Genuity lowers target price from 275p to 272p and downgrades from buy to hold.Faroe Petroleum: Oriel shits target price from 200p to 205p and stays with a buy recommendation.Hogg Robinson: Canaccord Genuity lowers target price from 110p to 100p and stays with its buy recommendation.IMI: Jefferies reduces target price from 1740p to 1655p and maintains a buy recommendation.Independend Oil & Gas: FinnCap initiates with a target price 59p and a buy recommendation.Mondi: Credit Suisse reduces target price from 1310p to 1215p and stays with an outperform rating.Morgan Advanced Materials: Jefferies cuts target price from 360p to 320p and downgrades from buy to hold.Petra Diamonds: Canaccord Genuity raises target price from 195p to 255p and reiterates a buy recommendation.Pets At Home Group: Oriel initiates with a target price of 165p and a reduce rating.Pittards: WH Ireland cuts target price from 220p to 180p and keeps a buy recommendation.Premier Foods: Investec places its target price (prev.: 67p) under review, while keeping a hold recommendation.Premier Oil: Numis downgrades from add to hold with a target price of 351p.Royal Main Group: Investec reduces target price from 560p to 490p and keeps a hold recommendation.Rotork: Jefferies reduces target price from 3333p to 2905p downgrading from buy to hold.Sainsbury: Nomura moves target price from 285p to 305p and retains a neutral rating.Senior: Jefferies cuts target price from 340p to 310p and keeps a buy recommendation.Seplat Petroleum: Morgan Stanley initiates with a target price of 300p and an equal-weight rating.Shanks Group: Credit Suisse lowers target price from 125p to 115p reiterating an outperform rating.Spectris: Jefferies reduces target price from 2690p to 2505p and maintains a buy recommendation.Spirax-Sarco Engineering: Jefferies reduces target price from 3285p to 2850p and reiterates a hold recommendation. Credit Suisse upgrades to outperform with a target price of 3030p.Spirent Communications: Jefferies cuts target price from 108p to 96p and keeps a hold recommendation.Tesco: Deutsche Bank cuts target price from 342p to 313p, while leaving its buy recommendation unchanged. Nomura shifts target price from 265p to 270p and maintains a neutral rating. Barclays cuts target price from 340p to 300p and reiterates an equal-weight rating.UBM: Panmure Gordon reduces target price from 940p to 590p and downgrades from buy to sell.Versarien: Westhouse Securities places both its target price (prev.: 35p) and its buy recommendation under review.Vodafone Group: Nomura lowers target price from 200p to 190p and keeps a neutral rating.Weir Group: Jefferies raises target price from 2335p to 2680p retaining a hold recommendation.
More News
31 Jul 2018 15:42

Berenberg changes mind on Abcam, reinstating 'buy' rating

(Sharecast News) - Analysts at Berenberg on Tuesday upgraded their rating for shares of Abcam from 'Hold' to 'Buy' after having downgraded shares of the antibodies supplier just three months ago.

Read more
31 Jul 2018 13:26

Tuesday broker round-up

(Sharecast News) - Abcam: Berenberg upgrades to buy with a target price of 1,640p.

Read more
18 Jun 2018 16:22

Abcam Appoints Former Celltech CFO As Non-Executive Chairman

LONDON (Alliance News) - Life sciences company Abcam PLC said Monday it has appointed the former chief financial officer of Celtech Group PLC as a non-executive chairman.Peter Allen is a at

Read more
9 May 2018 16:16

UPDATE: Horizon Discovery Outlook Strong In Face Of Abcam Pull-Out

LONDON (Alliance News) - Horizon Discovery Group PLC on Wednesday noted Abcam PLC's statement earlier in the day it will not be making an offer for Horizon.The gene modulation company a

Read more
9 May 2018 12:33

Abcam Decides Not To Make An Offer For Horizon Discovery Group

LONDON (Alliance News) - Abcam PLC on Wednesday said it has ended plans to make an offer for Horizon Discovery Group PLC following the latter's release of its annual results and a management a

Read more
2 May 2018 18:25

Horizon Discovery Confirms Rejected "Unsolicited" Abcam Proposal

LONDON (Alliance News) - Genomics firm Horizon Discovery Group PLC on Wednesday confirmed it had rejected an unsolicited and "highly conditional" proposal from Abcam PLC.The life

Read more
2 May 2018 16:41

Horizon Discovery Rejects GBP270.0 Million Proposal From Abcam

LONDON (Alliance News) - Abcam PLC on Wednesday said gene editing company Horizon Discovery Group PLC has rejected its acquisition proposal.The life science e-commerce company said it a for

Read more
15 Mar 2018 09:53

BROKER RATINGS SUMMARY: Barclays Reviews Banks, Goldman Property Firms

LONDON (Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:----------FTSE WITH

Read more
7 Mar 2018 15:23

FDA head Gottlieb criticizes industry for "Kabuki drug-pricing"

WASHINGTON, March 7 (Reuters) - U.S. Food and Drug Administrator Scott Gottlieb on Wednesday criticized drugmakers, pharmacy benefit managers and health a

Read more
11 Jan 2017 09:36

BROKER RATINGS SUMMARY: Morgan Stanley Upgrades BT To Overweight

Read more
10 Jan 2017 10:30

Abcam's revenue to be ahead of expectations

(ShareCast News) - Cambridge-based life science company Abcam said it anticipates revenue will continue to grow in the second half of the year, ahead of expectations. The AIM-listed company company expects revenue to grow 10% on a constant currency basis and 30% on a reported basis as it is on track

Read more
24 Oct 2016 10:28

Abcam commits to massive new Cambridge headquarters

(ShareCast News) - Life science research tools supplier Abcam announced on Monday that it has committed to the lease of a new facility for its global headquarters at the Biomedical Campus in Cambridge, subject to the grant of full planning approval. The AIM-traded firm said the purpose-built facilit

Read more
28 Sep 2016 11:29

DIRECTOR DEALINGS: Abcam COO Donates 62,000 Shares to Charity

Read more
12 Sep 2016 10:40

Abcam earnings dip slightly in year of investment

(ShareCast News) - Life science research tool supplier Abcam announced its preliminary results for the year to 30 June on Monday, with catalogue revenue increasing by 17.4% on a reported basis to £159.0m. The AIM-traded firm said at constant exchange rates the increase was 14.4%. Total revenue incr

Read more
2 Sep 2016 10:21

Abcam to place shares on AIM to pay vendors following acquisition

(ShareCast News) - Life science company Abcam is to pay the first performance-based payment of $5.2m for its acquisition of AmioMx through a share placing on AIM, the London Stock Exchange's junior market. The Cambridge-based company bought AmioMx in November 2015 which included an agreement to make

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.